by John Hatfield | Jun 12, 2023 | Events, Home Page Featured Story, May 2023
Countdown to DSCSA Panel Discussion at RFID Live! May 2023 On May 10th, the Axia Institute’s Dr. Bahar Aliakbarian participated in a panel discussion at RFID Live with Gregg Gorniak of largest pharmaceutical distributor AmerisourceBergen, John DiPalo of software...
by axia_82w8h3 | Mar 10, 2023 | Home Page Featured Story, March 2023, News
Axia’s Dr. Bahar Aliakbarian is Researching Ways to Repurpose Agricultural Waste March 2023 In a recent article published by Michigan State University, Dr. Bahar Aliakbarian discusses her research at the Axia Institute aimed at helping agricultural supply chains...
by John Hatfield | Mar 8, 2023 | February 2023, Home Page Featured Story, News
Axia Whitepaper on Orientation Positions for Testing: Orientation Testing on Pharmaceutical Syringes February 2023 This case study conducted by researchers at the Axia Institute aims to provide testing protocols and determine the effects of sample orientation and drug...
by axia_82w8h3 | Feb 22, 2023 | February 2023, Home Page Featured Story, News
John Hatfield Shares Presentation on Value Chain and Innovation at an Event Hosted by the Midland Business Alliance February 2023 Discussing the Importance of Value Chain for Innovators with Area Business Leaders:On February 9, 2023, the Midland Business Alliance...
by axia_82w8h3 | Jan 3, 2023 | December 2022, Home Page Featured Story, News
Bahar Aliakbarian Teaches at University of Genoa as Visiting Professor December 2022 In December the Axia Institute’s Dr. Bahar Aliakbarian spent a couple weeks teaching as a visiting professor at the University of Genoa in their Department of Civil, Chemical, and...
by axia_82w8h3 | Dec 13, 2022 | Events, Home Page Featured Story, October 2022
Bahar Aliakbarian Presents at RAIN RFID Alliance’s Healthcare Workgroup October 2022 The Axia Institute’s Research and Development Director, Dr. Bahar Aliakbarian, traveled to Greenville, South Carolina to present at the RAIN In Motion Conference as a part...
Recent Comments